Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials
Background Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Re...
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-12-01
|
Series: | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
Subjects: | |
Online Access: | https://www.ahajournals.org/doi/10.1161/JAHA.121.025275 |
_version_ | 1811170031625568256 |
---|---|
author | Maayan Konigstein Björn Redfors Zixuan Zhang Lak N. Kotinkaduwa Gary S. Mintz Pieter C. Smits Patrick W. Serruys Clemens von Birgelen Mahesh V. Madhavan Mordechai Golomb Ori Ben‐Yehuda Roxana Mehran Martin B. Leon Gregg W. Stone |
author_facet | Maayan Konigstein Björn Redfors Zixuan Zhang Lak N. Kotinkaduwa Gary S. Mintz Pieter C. Smits Patrick W. Serruys Clemens von Birgelen Mahesh V. Madhavan Mordechai Golomb Ori Ben‐Yehuda Roxana Mehran Martin B. Leon Gregg W. Stone |
author_sort | Maayan Konigstein |
collection | DOAJ |
description | Background Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Results Patient‐level data from 7 prospective, randomized trials were pooled. Clinical outcomes of patients undergoing single lesion percutaneous coronary intervention with second‐generation drug‐eluting stent were analyzed according to modified ACC/AHA lesion class. The primary end point was target lesion failure (TLF: composite of cardiac death, target vessel myocardial infarction, or ischemia‐driven target lesion revascularization). Clinical outcomes to 5 years were compared between patients treated for noncomplex (class A/B1) versus complex (class B2/C) lesions. Eight thousand five hundred sixteen patients (age 63.1±10.8 years, 70.5% male) were analyzed. Lesions were classified as A, B1, B2, and C in 7.9%, 28.5%, 33.7%, and 30.0% of cases, respectively. Target lesion failure was higher in patients undergoing percutaneous coronary intervention of complex versus noncomplex lesions at 30 days (2.0% versus 1.1%, P=0.004), at 1 year (4.6% versus 3.0%, P=0.0005), and at 5 years (12.4% versus 9.2%, P=0.0001). By multivariable analysis, treatment of ACC/AHA class B2/C lesions was significantly associated with higher rate of 5‐year target lesion failure (adjusted hazard ratio, 1.39 [95% CI, 1.17–1.64], P=0.0001) driven by significantly higher rates of target vessel myocardial infarction and ischemia‐driven target lesion revascularization. Conclusions In this pooled large‐scale analysis, treating complex compared with noncomplex lesions according to the modified ACC/AHA classification with second‐generation drug‐eluting stent was associated with worse 5‐year clinical outcomes. This historical classification system may be useful in the contemporary era for predicting early and late outcomes following percutaneous coronary intervention. |
first_indexed | 2024-04-10T16:50:47Z |
format | Article |
id | doaj.art-51dbe898fe084a8ea656381d9bc2242c |
institution | Directory Open Access Journal |
issn | 2047-9980 |
language | English |
last_indexed | 2024-04-10T16:50:47Z |
publishDate | 2022-12-01 |
publisher | Wiley |
record_format | Article |
series | Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease |
spelling | doaj.art-51dbe898fe084a8ea656381d9bc2242c2023-02-07T16:03:49ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802022-12-01112410.1161/JAHA.121.025275Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized TrialsMaayan Konigstein0Björn Redfors1Zixuan Zhang2Lak N. Kotinkaduwa3Gary S. Mintz4Pieter C. Smits5Patrick W. Serruys6Clemens von Birgelen7Mahesh V. Madhavan8Mordechai Golomb9Ori Ben‐Yehuda10Roxana Mehran11Martin B. Leon12Gregg W. Stone13Clinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYMaasstad Ziekenhuis Rotterdam The NetherlandsImperial College of Science, Technology and Medicine London United KingdomDepartment of Cardiology Thoraxcentrum Twente, Medisch Spectrum Twente Enschede The NetherlandsClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYClinical Trials Center Cardiovascular Research Foundation New York NYUniversity of California ‐ San Diego Health – La Jolla and Hillcrest Hospitals San Diego CABackground Use of the modified American College of Cardiology (ACC)/American Heart Association (AHA) lesion classification as a prognostic tool to predict short‐ and long‐term clinical outcomes after percutaneous coronary intervention in the modern drug‐eluting stent era is uncertain. Methods and Results Patient‐level data from 7 prospective, randomized trials were pooled. Clinical outcomes of patients undergoing single lesion percutaneous coronary intervention with second‐generation drug‐eluting stent were analyzed according to modified ACC/AHA lesion class. The primary end point was target lesion failure (TLF: composite of cardiac death, target vessel myocardial infarction, or ischemia‐driven target lesion revascularization). Clinical outcomes to 5 years were compared between patients treated for noncomplex (class A/B1) versus complex (class B2/C) lesions. Eight thousand five hundred sixteen patients (age 63.1±10.8 years, 70.5% male) were analyzed. Lesions were classified as A, B1, B2, and C in 7.9%, 28.5%, 33.7%, and 30.0% of cases, respectively. Target lesion failure was higher in patients undergoing percutaneous coronary intervention of complex versus noncomplex lesions at 30 days (2.0% versus 1.1%, P=0.004), at 1 year (4.6% versus 3.0%, P=0.0005), and at 5 years (12.4% versus 9.2%, P=0.0001). By multivariable analysis, treatment of ACC/AHA class B2/C lesions was significantly associated with higher rate of 5‐year target lesion failure (adjusted hazard ratio, 1.39 [95% CI, 1.17–1.64], P=0.0001) driven by significantly higher rates of target vessel myocardial infarction and ischemia‐driven target lesion revascularization. Conclusions In this pooled large‐scale analysis, treating complex compared with noncomplex lesions according to the modified ACC/AHA classification with second‐generation drug‐eluting stent was associated with worse 5‐year clinical outcomes. This historical classification system may be useful in the contemporary era for predicting early and late outcomes following percutaneous coronary intervention.https://www.ahajournals.org/doi/10.1161/JAHA.121.025275drug‐eluting stentspercutaneous coronary interventiontarget lesion failure |
spellingShingle | Maayan Konigstein Björn Redfors Zixuan Zhang Lak N. Kotinkaduwa Gary S. Mintz Pieter C. Smits Patrick W. Serruys Clemens von Birgelen Mahesh V. Madhavan Mordechai Golomb Ori Ben‐Yehuda Roxana Mehran Martin B. Leon Gregg W. Stone Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease drug‐eluting stents percutaneous coronary intervention target lesion failure |
title | Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials |
title_full | Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials |
title_fullStr | Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials |
title_full_unstemmed | Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials |
title_short | Utility of the ACC/AHA Lesion Classification to Predict Outcomes After Contemporary DES Treatment: Individual Patient Data Pooled Analysis From 7 Randomized Trials |
title_sort | utility of the acc aha lesion classification to predict outcomes after contemporary des treatment individual patient data pooled analysis from 7 randomized trials |
topic | drug‐eluting stents percutaneous coronary intervention target lesion failure |
url | https://www.ahajournals.org/doi/10.1161/JAHA.121.025275 |
work_keys_str_mv | AT maayankonigstein utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT bjornredfors utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT zixuanzhang utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT laknkotinkaduwa utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT garysmintz utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT pietercsmits utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT patrickwserruys utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT clemensvonbirgelen utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT maheshvmadhavan utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT mordechaigolomb utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT oribenyehuda utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT roxanamehran utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT martinbleon utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials AT greggwstone utilityoftheaccahalesionclassificationtopredictoutcomesaftercontemporarydestreatmentindividualpatientdatapooledanalysisfrom7randomizedtrials |